Thomas F. Deuel

Thomas F. Deuel

President at Edward R. Mallinckrodt Foundation

89 year
Consumer Services
Health Technology
Commercial Services

Profile

Dr. Thomas F.
Deuel
, MD, is Independent Director at Enzon Pharmaceuticals, Inc., a Director-Vascular Biology Affinity Group at The Scripps Research Institute, a Professor-Emeritus at Harvard Medical School, President at Edward R.
Mallinckrodt Foundation, and a Member at Institute of Medicine.
He is on the Board of Directors at Enzon Pharmaceuticals, Inc. Dr. Deuel also served on the board at ImClone Systems, Inc. and Beth Israel Hospital.
Dr. Deuel received his undergraduate degree from Princeton University and a doctorate degree from Columbia University.

Thomas F. Deuel active positions

CompaniesPositionStart
Corporate Officer/Principal 2002-01-31
Edward R. Mallinckrodt Foundation President -
Harvard Medical School Corporate Officer/Principal 1997-12-31
Corporate Officer/Principal -
Corporate Officer/Principal -
All active positions of Thomas F. Deuel

Former positions of Thomas F. Deuel

CompaniesPositionEnd
ENZON PHARMACEUTICALS, INC. Director/Board Member 2013-10-21
Director/Board Member 2008-11-23
Corporate Officer/Principal 2001-12-31
See the detail of Thomas F. Deuel's experience

Training of Thomas F. Deuel

The Trustees of Columbia University in The City of New York Doctorate Degree
Princeton University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas F. Deuel's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ENZON PHARMACEUTICALS, INC.

Health Technology

Private companies5

Health Technology

Health Services

Edward R. Mallinckrodt Foundation

Commercial Services

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Thomas F. Deuel